Cancer Immunotherapy with Immune Checkpoint Inhibitors-Biomarkers of Response and Toxicity; Current Limitations and Future PromiseBrian Bird, Stephen P. Finn, Sylvie Amu et al.|Diagnostics|2022Cited by 28
Loss of SFRP1 expression is a key progression event in gastrointestinal stromal tumor pathogenesisCher‐Wei Liang, Jen‐Chieh Lee, Ching‐Yao Yang et al.|Human Pathology|2020Cited by 7